Roland Geisberger

Dr. Roland Geisberger serves as the Head of Workgroup in the Division of Hematology, Medical Oncology, Hemostaseology, Rheumatology, Infectiology, and Oncologic Center. His research focuses on leukemia pathogenesis, molecular oncology, and precision medicine. Key areas include Chronic Myeloid Leukemia (CML), B-cell malignancies, and drug resistance mechanisms.

Research Interests:

• TRPM7 channel modulation in CML therapy
• Richter Transformation mechanisms in CLL
• Combined DNA analysis for tumor tracking
• MTOR signaling in oncogenesis

Recent Projects (PI):

• "DNA repair pathway decisions in normal and malignant B cells" (Active since 2022)
• "Unravelling ADARB1 dependent C to U RNA editing in CLL" (2021-2022)

Collaborations:

Cooperation in bioinformatics and sequencing data analysis (2014).